The Impact of 2013 ASCO/CAP Guidelines on the Practice of HER2 Testing in a Reference Laboratory

被引：0
|
作者：
Hanna, Wedad [1 ]
Slodkowska, Elzbieta [1 ]
Lu, Fang-I [1 ]
Han, Guangming [1 ]
Nafisi, Houman [1 ]
Nofech-Mozes, Sharon [1 ]
机构：
[1] Univ Toronto, SHSC, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
167
引用
收藏
页码：44A / 44A
页数：1
相关论文
共 50 条
  • [21] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    Lauren E. McLemore
    Constance T. Albarracin
    Stephen K. Gruschkus
    Roland L. Bassett
    Yun Wu
    Sagar Dhamne
    Isaiah Yim
    Kevin Lin
    Isabelle Bedrosian
    Nour Sneige
    Hui Chen
    Breast Cancer Research and Treatment, 2021, 187 : 95 - 104
  • [22] COMPARISON OF THE 2007 AND 2013 ASCO/CAP GUIDELINES FOR HER2 ISH TESTING IN INVASIVE BREAST CANCER PATIENTS
    Salido, M.
    Puiggros, A.
    Corominas, J. M.
    Iglesias, M.
    Rodriguez-Rivera, M.
    Melero, C.
    Tusquets Trias Bes, I.
    Albanell, J.
    Serrano, S.
    Servitja Tormo, S.
    Espinet, B.
    ANNALS OF ONCOLOGY, 2014, 25
  • [23] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines-Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    MODERN PATHOLOGY, 2019, 32
  • [24] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines- Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    LABORATORY INVESTIGATION, 2019, 99
  • [25] Impact of the Updated 2018 ASCO/CAP HER2 Guidelines: A Retrospective Study
    Wu, Jessie
    Mullen, Brendan
    Mrkonjic, Miralem
    Turashvili, Gulisa
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 287 - 288
  • [26] Impact of the Updated 2018 ASCO/CAP HER2 Guidelines: A Retrospective Study
    Wu, Jessie
    Mullen, Brendan
    Mrkonjic, Miralem
    Turashvili, Gulisa
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 287 - 288
  • [27] ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia
    Farshid, Gelareh
    Bilous, Michael
    Morey, Adrienne
    Fox, Stephen
    Lakhani, Sunil
    Loi, Sherene
    Bell, Richard
    Spillane, Andrew
    PATHOLOGY, 2019, 51 (04) : 345 - 348
  • [28] The updated ASCO/CAP guidelines for HER2 testing create more uncertainty for clinicians
    Chen, J.
    Klein, P.
    Shao, T.
    CANCER RESEARCH, 2016, 76
  • [29] HER2 testing in breast cancers: Comparison of Assays and Interpretation Using ASCO-CAP 2013 with 2018 guidelines
    Mclemore, Lauren
    Albarracin, Constance
    Chen, Hui
    Bassett, Roland
    Dhamne, Sagar
    Gruschkus, Stephen
    Yim, Isaiah
    Lin, Kevin
    Wu, Yun
    MODERN PATHOLOGY, 2019, 32
  • [30] Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution
    Portier, B. P.
    Downs-Kelly, E.
    Lanigan, C.
    Cotta, C.
    Patil, D.
    Procop, G.
    Cook, J. R.
    Moore, H.
    Budd, G. T.
    Tubbs, R. R.
    LABORATORY INVESTIGATION, 2011, 91 : 436A - 436A
12345